Hedge funds employ such experts in research departments to provide insights on company growth prospects. — Reuters
LONDON: Some of the world’s largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the prospects for pharmaceutical stocks after big share swings in the sector, sources say.
This year has seen sharp stock moves as companies report financial results and update investors on early and mid-stage drug studies.
